Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Clinical Neuropharmacology|March 10, 2025
The Impact of Age and Severity of Attention Deficit Hyperactivity Disorder (ADHD) Before COVID-19 on the Severity of ADHD During the COVID-19 Lockdowns, as Reported by the MothersPavel Golubchik, Abraham WeizmanInternational Clinical Psychopharmacology|October 21, 2020
Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative reviewPavel Golubchik, Abraham WeizmanInternational Journal of Psychiatry in Clinical Practice|September 30, 2017
The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODDPavel Golubchik, Abraham WeizmanJournal of Child and Adolescent Psychopharmacology|April 12, 2017
The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant DisorderPavel Golubchik, Abraham WeizmanInternational Clinical Psychopharmacology|January 31, 2020
Poor performance of the 'child Reading the Mind in the Eyes Test' correlates with poorer social-emotional functioning in children with attention-deficit/hyperactivity disorderPavel Golubchik, Abraham WeizmanClinical Neuropharmacology|March 19, 2013
Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trialPavel Golubchik, Jonathan Sever, Abraham WeizmanClinical Neuropharmacology|November 24, 2016
No Superiority of Treatment With Osmotic Controlled-Release Oral Delivery System-Methylphenidate Over Short/Medium-Acting Methylphenidate Preparations in the Rate and Timing of Injuries in Children With Attention-Deficit/Hyperactivity DisorderPavel Golubchik, Arad Kodesh, Abraham WeizmanClinical Neuropharmacology|October 17, 2009
Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disordersPavel Golubchik, Jonathan Sever, Abraham WeizmanClinical Neuropharmacology|October 15, 2011
Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trialPavel Golubchik, Jonathan Sever, Abraham WeizmanClinical Neuropharmacology|September 19, 2013
Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?Pavel Golubchik, Arad Kodesh, Abraham WeizmanPageof 5